[ad_1] Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for…
Browsing: Amgen
[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple…
[ad_1] Amgen (NASDAQ:AMGN) announced Friday that its Phase 2 DeLLphi-301 study for bispecific T-cell engager tarlatamab showed an objective response…
[ad_1] A box of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk.George Frey…
[ad_1] Mohammed Haneefa Nizamudeen As the FDA continues to mull the fate of Amgen’s lung cancer drug Lumakras, Sanofi is…
[ad_1] Amgen Inc. said it would continue to work closely with the Food and Drug Administration to seek full approval…
[ad_1] © Reuters. HSBC initiated coverage of 11 U.S. biopharmaceutical and healthcare stocks in a note to clients on Wednesday.…
[ad_1] Here are Wednesday’s biggest calls on Wall Street: UBS upgrades Toast to buy from neutral UBS said the restaurant…
[ad_1] Amgen (NASDAQ:) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application…
[ad_1] JHVEPhoto Amgen (NASDAQ:AMGN) has reportedly hired Moderna’s (NASDAQ:MRNA) chief medical officer, Paul Burton, as its new chief medical officer.…